What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Surgery
Robert Landewé mostly deals with Internal medicine, Rheumatoid arthritis, Physical therapy, Ankylosing spondylitis and Surgery.
His Internal medicine research incorporates themes from Gastroenterology and Placebo.
The study incorporates disciplines such as Erythrocyte sedimentation rate, Connective tissue disease and Methotrexate in addition to Rheumatoid arthritis.
His Physical therapy research integrates issues from Clinical trial, Systematic review, Rheumatism, Evidence-based medicine and Severity of illness.
His study looks at the relationship between Ankylosing spondylitis and fields such as Cohort, as well as how they intersect with chemical problems.
His Surgery study incorporates themes from Odds ratio, Epidemiology, Combination therapy and Sulfasalazine.
His most cited work include:
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection (1871 citations)
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs (1282 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Physical therapy, Rheumatoid arthritis, Ankylosing spondylitis and In patient.
Robert Landewé has researched Internal medicine in several fields, including Gastroenterology, Placebo and Surgery.
His research investigates the connection between Physical therapy and topics such as Clinical trial that intersect with issues in Observational study.
Robert Landewé has included themes like Methotrexate, Disease, Combination therapy and Arthritis in his Rheumatoid arthritis study.
His Ankylosing spondylitis study integrates concerns from other disciplines, such as BASFI, BASDAI and Radiography.
The Rheumatology study combines topics in areas such as Severity of illness and Etanercept.
He most often published in these fields:
- Internal medicine (52.61%)
- Physical therapy (31.07%)
- Rheumatoid arthritis (29.25%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (52.61%)
- Axial spondyloarthritis (17.01%)
- In patient (22.34%)
In recent papers he was focusing on the following fields of study:
Robert Landewé focuses on Internal medicine, Axial spondyloarthritis, In patient, Ankylosing spondylitis and Cohort.
His study ties his expertise on Placebo together with the subject of Internal medicine.
Robert Landewé combines subjects such as Family medicine, Certolizumab pegol and Radiography with his study of Axial spondyloarthritis.
His work carried out in the field of Ankylosing spondylitis brings together such families of science as Randomized controlled trial, BASDAI, Severity of illness and Confounding.
His Cohort research includes themes of Sacroiliitis, Disease, Generalized estimating equation, Back pain and Physical therapy.
His Rheumatoid arthritis study combines topics in areas such as Clinical trial, Intensive care medicine and Arthritis.
Between 2017 and 2021, his most popular works were:
- Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force (260 citations)
- 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases (144 citations)
- TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort (124 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Surgery
Robert Landewé spends much of his time researching Internal medicine, Ankylosing spondylitis, Axial spondyloarthritis, Rheumatoid arthritis and In patient.
His Internal medicine research is multidisciplinary, incorporating elements of Placebo and Radiography.
His study in Ankylosing spondylitis is interdisciplinary in nature, drawing from both Adalimumab, Severity of illness, Confounding and Clinical trial.
His Axial spondyloarthritis study combines topics from a wide range of disciplines, such as Latent transition analysis, Physical therapy, Magnetic resonance imaging and Class.
His study focuses on the intersection of Physical therapy and fields such as Outcomes research with connections in the field of Absenteeism.
He interconnects Disease activity, Methotrexate, Incidence and Arthritis in the investigation of issues within Rheumatoid arthritis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
